Study for children with wheezing or asthma symptoms
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A parent can sign consent (and your child may need to agree if over age 8)
- Your child is between 6 months and 18 years old
- Your child was born at term (at least 37 weeks pregnancy)
- You can communicate in German (at least enough to understand the study)
- If your child is under 6: they have had more than 2 wheezing episodes in the past 12 months; if 6 or older: a doctor has diagnosed asthma
- Your child should not have certain lung or breathing conditions or other major health problems that could explain symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This study follows children and teens who are being checked for asthma for the first time. It aims to learn more about the early symptoms of asthma to improve diagnosis and treatment.
This study collects information from children and teens (up to age 16) who are seen in a children’s lung clinic for breathing or respiratory problems in Switzerland. The goal is to better understand these conditions in everyday care, which may help improve future diagnosis and treatment.
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
This study follows adults with asthma to better understand the disease and help improve care. It checks basic eligibility such as diagnosis, language, and recent health history.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.